The relationship between systemic anticoagulation during cardiac surgery and heparin platelet factor 4 antibody formation.

被引：1
|
作者：
Francis, JL [1 ]
Drexler, A [1 ]
Walker, J [1 ]
Rathmann, K [1 ]
机构：
[1] Florida Hosp Med Ctr, Ctr Thrombosis & Hemostasis, Orlando, FL 32803 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3951.3951
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3951
引用
收藏
页码：74B / 74B
页数：1
相关论文
共 50 条
  • [31] Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery
    Demir, Muzaffer
    Duran, Enver
    Yigitbasi, Omer
    Vural, Ozden
    Kurum, Turhan
    Yuksel, Mahmut
    Turgut, Burhan
    Walenga, Jeanine M.
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (03) : 279 - 284
  • [32] Murine Monoclonal Antibody to Platelet Factor 4/Heparin Complexes as a Potential Reference Standard for Platelet Activation Assays in Heparin-Induced Thrombocytopenia
    Asada, Reiko
    Wanaka, Keiko
    Walenga, Jeanine
    Prechel, Margaret
    Miyashita, Kumiko
    Escalante, Vicki
    Kaneko, Chieko
    Hoshino, Nobuhiro
    Oosawa, Mitsuru
    Matsuo, Miyako
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (01) : 37 - 41
  • [33] Heparin-induced antibody formation and platelet activation in patients undergoing cardiopulmonary bypass surgery.
    Bauer, TL
    Arepalli, G
    Konkle, BA
    Mestichelli, B
    Shapiro, SS
    Cines, DB
    Poncz, M
    McNulty, S
    Edie, RN
    Mannion, JD
    BLOOD, 1995, 86 (10) : 2188 - 2188
  • [34] Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
    Alberio, L
    Kimmerle, S
    Baumann, A
    Taleghani, BRM
    Biasiutti, FD
    Lämmle, B
    AMERICAN JOURNAL OF MEDICINE, 2003, 114 (07): : 528 - 536
  • [35] Performance of 4T score and heparin–platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer
    Myra Wong
    Thein Hlaing Oo
    Wei Qiao
    Naveen Garg
    Cristhiam M. Rojas-Hernandez
    Journal of Thrombosis and Thrombolysis, 2017, 44 : 261 - 266
  • [36] Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies
    Strobel, Erwin
    BLOOD TRANSFUSION, 2017, 15 (03) : 268 - 271
  • [37] Similar prevalence of platelet factor 4/heparin immunoglobulin G antibodies in patients following cardiac surgery and other patients suspected of heparin-induced thrombocytopaenia
    Bryk, Agata H.
    Mazur, Piotr
    Zdziarska, Joanna
    Kuczia, Pawel
    Plens, Krzysztof
    Lesniak-Sobelga, Agata
    Wypasek, Ewa
    Undas, Anetta
    KARDIOLOGIA POLSKA, 2018, 76 (09) : 1372 - 1375
  • [38] Increased prevalence of anti-heparin platelet factor 4 antibodies in antiphospholipid antibody-positive patients without systemic lupus erythematosus
    Alpert, Deborah R.
    Erkan, Doruk
    Mandl, Lisa A.
    Yin, Wei
    Peerschke, Ellinor I.
    Roubey, Robert A. S.
    Salmon, Jane E.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4239 - 4240
  • [39] The relationship between heparin level and activated clotting time in the adult cardiac surgery population
    FitzGerald, D. J.
    Patel, A.
    Body, S. C.
    Garvin, S.
    PERFUSION-UK, 2009, 24 (02): : 93 - 96
  • [40] Relationship between estimated and observed heparin sensitivity indices in cardiac and thoracic aortic surgery
    Hitomi Nakatani
    Mitsuru Ida
    Taichi Kotani
    Masahiko Kawaguchi
    JA Clinical Reports, 9
12345